DXCM Dexcom Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Air Circular Clean Climate Contaminant Coral Environment Environmental Forest Leach Life Cycle Lifecycle Materials Mineral Natural Resources Nature Offset Package Packaging Pandemic Plastic Raw Materials Waste Access Affordability African American Benefits Black California Consumer Privacy Act Citizenship Collective Bargaining Community Culture Customer Customer Satisfaction Cyber Cybersecurity Data Privacy Data Security Death Demographics Disability Diversity Employee Employee Engagement Employee Resource Group Engagement Frontline Workers Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Human Capital Human Resources Incident Injury Latinx Minority Opioid Pay Equity Pay for Performance Pay Parity Perquisites Privacy Product Quality Recall Recruit Reimbursement Retention Retirement Safety Satisfaction Skilled Skills Social Stakeholder Supplier Supply Chain Supply Chain Management Talent Training Union Volunteer Women Workers Workforce Workplace Safety Action Plan Anti-corruption Assessment Assurance Attorney General Attorneys General Audit Board Evaluation Bonus Bribery Chronic Classified Classified Board Clawback Commitment Conflict of Interest Corporate Governance Corporate Purpose Corporate Social Responsibility Corruption Department of Enterprise Risk Management ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovate Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Materiality Oversee Oversight Perquisite Plaintiff Pledging Procurement Proxy Access Proxy Contest Purpose Quality Standard Reputation Reputational Research and Development Responsibility Responsible Self-evaluation Single Trigger Special Meeting Stockholder Outreach Strategy Sustainability Sustainable Targets Tax Tenure Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

(a) DexCom, Inc. (“DexCom”) held its Annual Meeting of Stockholders (the “Annual Meeting”) on May 21, 2020. Proxies for the Annual Meeting were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended. At the close of business on the record date, there were 92,344,868 shares outstanding and entitled to vote and 82,868,501 shares were voted in person or by proxy on the matters described below.

(b) The matters described below were voted on at the Annual Meeting and the number of votes cast with respect to each matter was as indicated:

(1) Holders of DexCom’s common stock voted to elect three Class III directors, each to serve until the DexCom’s 2023 annual meeting of stockholders and until their successor has been elected and qualified, or until their earlier death, resignation or removal as follows:


Name	For (#)		Against (#)		Abstentions (#)		Broker Non- Votes
Richard A. Collins		76,890,953		349,639		42,535		5,585,374
Mark G. Foletta		75,399,498		1,843,801		39,828		5,585,374
Eric J. Topol, M.D.		74,925,645		2,329,887		27,595		5,585,374

(2) Holders of DexCom’s common stock voted to ratify the appointment of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2020:


	Number of Shares
Shares Voted in Favor:		81,480,281
Shares Voted Against:		1,356,391
Shares Abstaining:		31,829

(3) Holders of DexCom’s common stock voted to approve the non-binding advisory resolution on compensation paid to DexCom’s named executive officers, as disclosed pursuant to